+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 60Years
All Genders
ID07777575

Evaluating Resistance Training Versus Usual Care to Prevent Muscle Loss During Treatment With Tirzepatide in Adults with Obesity A Phase IV Randomized Controlled Trial

Led by Technical University of Munich · Updated on 2026-10-20

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of resistance training compared to usual care on thigh muscle volume in adults with obesity who are receiving the dual GIPGLP-1 receptor agonist tirzepatide. Tirzepatide is known to cause significant weight loss, but rapid weight loss may also lead to muscle loss, which can reduce metabolic rate, increase insulin resistance, limit mobility, and cause other long-term issues. This Phase IV randomized controlled trial aims to evaluate how resistance training might prevent muscle loss during treatment with tirzepatide. Participants will receive tirzepatide, which will be gradually increased to a maximum tolerated dose of up to 10 mg per week, alongside individual diet and physical activity counseling. The study compares two groups one receiving tirzepatide alone and the other receiving tirzepatide combined with low-volume, high-intensity resistance training performed three days a week. The treatment period lasts 24 weeks. During the study, participants will undergo assessments including MRI scans to measure thigh muscle volume and fat, strength tests such as handgrip and knee extension torque, physical activity tracking, and quality of life questionnaires. Researchers will monitor adherence to the medication and resistance training. The main outcome is the change in contractile thigh muscle volume from the start to the end of treatment. The total study duration for each participant is 24 weeks.

CONDITIONS

Brief Title

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Research Team

S

Stephan Mueller-Stegner, Dr rer nat

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here